Basic Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Oct 14, 2020; 26(38): 5822-5835
Published online Oct 14, 2020. doi: 10.3748/wjg.v26.i38.5822
Figure 6
Figure 6 Acetyl-11-keto-β-boswellic acid inhibits gastric cancer tumor growth in vivo. Twenty nude mice were subcutaneously injected with BGC823 and SGC7901 cells. When tumor size was approximately 0.1 cm3, the nude mice were randomly divided into different groups (n = 5) to receive different treatments. A: Acetyl-11-keto-β-boswellic acid (AKBA) inhibits gastric cancer xenograft tumor growth in vivo; B: Tumor volume was measured, and the tumor growth curves were plotted; C: Body weight change in the nude mice treated with saline or AKBA; D: Western blot analysis of cyclooxygenase (COX)-2 protein expression in gastric cancer tissues of control and AKBA treated nude mice (100 mg/kg/d); E: Histogram representing the relative expression of COX-2 compared with that of GAPDH. aP < 0.05, bP < 0.01 vs control (saline). AKBA: Acetyl-11-keto-β-boswellic acid.